These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 2473654
21. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro. Taniguchi H, Yazaki N, Endo T, Nagasaki M. Eur J Pharmacol; 1996 May 23; 304(1-3):147-54. PubMed ID: 8813597 [Abstract] [Full Text] [Related]
22. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. Niederau M, Niederau C, Strohmeyer G, Grendell JH. Am J Physiol; 1989 Jan 23; 256(1 Pt 1):G150-7. PubMed ID: 2463767 [Abstract] [Full Text] [Related]
23. Asperlicin: a unique nonpeptide cholecystokinin antagonist. Zucker KA, Adrian TE, Zdon MJ, Ballantyne GH, Modlin IM. Surgery; 1987 Aug 23; 102(2):163-70. PubMed ID: 2441481 [Abstract] [Full Text] [Related]
24. Structural features of various proglumide-related cholecystokinin receptor antagonists. Jensen RT, Zhou ZC, Murphy RB, Jones SW, Setnikar I, Rovati LA, Gardner JD. Am J Physiol; 1986 Dec 23; 251(6 Pt 1):G839-46. PubMed ID: 2431626 [Abstract] [Full Text] [Related]
25. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors. Motomura Y, Chijiiwa Y, Iwakiri Y, Nawata H. Life Sci; 1997 Dec 23; 60(7):499-504. PubMed ID: 9042379 [Abstract] [Full Text] [Related]
26. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini. Tashiro M, Hirohata Y, Kihara Y, Akiyama T, Otsuki M. Pancreas; 1999 Mar 23; 18(2):156-64. PubMed ID: 10090413 [Abstract] [Full Text] [Related]
27. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum. D'Amato M, Stamford IF, Bennett A. Br J Pharmacol; 1991 Feb 23; 102(2):391-5. PubMed ID: 2015421 [Abstract] [Full Text] [Related]
28. Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig. Morini G, Barocelli E, Impicciatore M, Grider JR, Makhlouf GM. Regul Pept; 1990 May 21; 28(3):313-21. PubMed ID: 2377745 [Abstract] [Full Text] [Related]
29. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats]. Wang SX. Zhongguo Yao Li Xue Bao; 1993 Sep 21; 14(5):443-6. PubMed ID: 8010038 [Abstract] [Full Text] [Related]
30. Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion. Tang LH, Miller MD, Goldenring JR, Modlin IM, Hersey SJ. Am J Physiol; 1993 Nov 21; 265(5 Pt 1):G865-72. PubMed ID: 8238515 [Abstract] [Full Text] [Related]
31. Characterization of cholecystokinin receptors on the sphincter of Oddi. Cox KL, von Schrenck T, Moran TH, Gardner JD, Jensen RT. Am J Physiol; 1990 Nov 21; 259(5 Pt 1):G873-81. PubMed ID: 2240227 [Abstract] [Full Text] [Related]
32. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat. Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S. Digestion; 1989 Nov 21; 42(2):61-9. PubMed ID: 2475379 [Abstract] [Full Text] [Related]
39. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Talkad VD, Patto RJ, Metz DC, Turner RJ, Fortune KP, Bhat ST, Gardner JD. Biochim Biophys Acta; 1994 Oct 20; 1224(1):103-16. PubMed ID: 7524683 [Abstract] [Full Text] [Related]